Structural Genomix Looks to Forge New Deals, Ramp Up Production in 2001 | GenomeWeb

SAN FRANCISCO, Jan 8 – Structural Genomix’ deal to jointly develop a new protein analysis system with Caliper Technologies represents one of two types of transactions the company is looking to forge, Linda Grais, Structural Genomix’ executive vice president and founder, said Monday.

"In some deals, we will be licensing technology in and in others we will sell information about protein structures," said Grais, who was attending the JP Morgan H&Q conference.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.